國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁 到查詢結果 [ subject:"NAD-ADP-ribosyltransferase" ]

切換: 標籤 | MARC模式 | ISBD

PARP as a therapeutic target

Zhang, Jei.

PARP as a therapeutic target

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	PARP as a therapeutic targetedited by Jei Zhang.
其他作者:	Zhang, Jei.
出版者:	Boca Raton, Fla. :CRC Press,c2002.
面頁冊數:	338 p. :ill.
標題:	NAD-ADP-ribosyltransferaseInhibitors
電子資源:	book distributed by CRC Press. Purchase or institutional license may be required for access.
ISBN:	9781420042405 (e-book : PDF)

PARP as a therapeutic target
PARP as a therapeutic target[electronic resource] /edited by Jei Zhang. - Boca Raton, Fla. :CRC Press,c2002. - 338 p. :ill. - Pharmacology and toxicology. - Pharmacology & toxicology (Boca Raton, Fla.).

Includes bibliographical references and index.

Machine generated contents note: Chapter 1 -- Nervous System Functions of Poly(ADP-Ribose) Polymerase-1 -- Krishna Juluri, Hyo Chol Ha, and Solomon H. Snyder -- Chapter 2 -- Role of Poly(ADP-Ribose) Polymerase- 1 in Neurologic Disorders -- Marc E Poitras, Valina L. Dawson, and Ted M. Dawson -- Chapter 3 -- Involvement of PARP-1 and Poly(ADP-Ribosyl)ation in the Maintenance of -- Genomic Stability -- Cynthia M. Simbulan-Rosenthal, Dean S. Rosenthal, Bassem H. Haddad, -- Danith Ly, Jie Zhang, and Mark E. Smulson -- Chapter 4 -- Functional Testing of Human PARP in Proliferation, Endotoxic Shock, and -- Radiosensitivity: A Genetic Rescue Study. -- Zdenko Herceg, Virginie Petrilli, Anton Wutz, Berhard Auer, Marie-Pierre Cros, -- and Zhao-Qi Wang -- Chapter 5 -- PARP Inhibitors as Neuroprotective Agents for Brain Injury -- Joel H. Greenberg, Michelle C. LaPlaca, and Tracy K. Mclntosh -- Chapter 6 -- PARP Inhibitors and Cardioprotection -- Christoph Thiemermann, Nicole Wayman, Michelle C. McDonald, and -- Prabal Kumar Chatterjee -- Chapter 7 -- Neuroprotection of the Retina with 3-Aminobenzamide, a PARP Inhibitor -- Tim T Lam -- Chapter 8 -- Poly(ADP-Ribose) Polymerase Inhibitors and Acute Renal Failure -- Prabal Kumar Chatterjee and Christoph Thiemermann -- Chapter 9 -- Role of Poly(ADP-Ribose) Polymerase Activation in the Pathogenesis of Shock and Inflammation -- Csaba Szabd -- Chapter 10 -- Clinical Development of the Nicotinamides and Benzamides Involving PARP as a Molecular Target. -- Ronald W. Pero, Anders Olsson, Hanna Lindgren, and Tomas Leanderson -- Chapter 11 -- Chemoprotective Effect of a Novel PARP Inhibitor -- Gyorgy Rabloczky, Laszlo Jaszlits, Gyorgy Bardos, Balazs Sumegi, Kalman Tory, -- Ildiko Racz, Beatrix Farkas, Attila Sandor, Zoltan Berente, Erzsebet Osz, -- Judit Szilvassy, Istvan Sziklai, Sandor Bernath, and Peter Literati Nagy -- Chapter 12 -- Beneficial Effect of GPI 6150 Treatment in Multiple Animal Models of Diseases -- Jie Zhang -- Chapter 13 -- Protecting Effect of PARP Inhibition on Ultraviolet Light-Induced Skin Damage -- Beatrix Farkas, Balazs Sumegi, Gyorgy Rabloczky, Bela Csete, Balazs Hodosi, -- Marta Magyarlaki, Sandor Bernath, and Peter Literati Nagy -- Chapter 14 -- Role of Poly(ADP-Ribose) Polymerase Activation in the Pathogenesis of Diabetes Mellitus and Diabetic Vascular Dysfunction. -- Jon G. Mabley, Ldszlo Virdg, and Csaba Szabd -- Chapter 15 -- Therapeutic Targeting of the PARPs: Future Challenges, Future Opportunities -- Myron K. Jacobson and Elaine L. Jacobson.

Mode of access: World Wide Web.

ISBN: 9781420042405 (e-book : PDF)Subjects--Topical Terms:

301695
NAD-ADP-ribosyltransferase
--InhibitorsIndex Terms--Genre/Form:

214472
Electronic books.

Dewey Class. No.: 615/.35

PARP as a therapeutic target
LDR:03621cmm 2200301 a 4500 001 277021
003 FlBoTFG
005 20090717103237.0
006 a s
007 cru
008 110120s2002 flua b 001 0 eng
020 $a 9781420042405 (e-book : PDF)
020 $a 9780849300738
035 $a CRC000E0073PDF
040 $a FlBoTFG $c FlBoTFG
082 0 0 $a 615/.35 $2 21
090 $a RM666.E548 $b P37 2002
092 $a 615.35 $b P257
245 0 0 $a PARP as a therapeutic target $h [electronic resource] / $c edited by Jei Zhang.
260 $a Boca Raton, Fla. : $b CRC Press, $c c2002.
300 $a 338 p. : $b ill.
490 1 $a Pharmacology and toxicology
504 $a Includes bibliographical references and index.
505 8 $a Machine generated contents note: Chapter 1 -- Nervous System Functions of Poly(ADP-Ribose) Polymerase-1 -- Krishna Juluri, Hyo Chol Ha, and Solomon H. Snyder -- Chapter 2 -- Role of Poly(ADP-Ribose) Polymerase- 1 in Neurologic Disorders -- Marc E Poitras, Valina L. Dawson, and Ted M. Dawson -- Chapter 3 -- Involvement of PARP-1 and Poly(ADP-Ribosyl)ation in the Maintenance of -- Genomic Stability -- Cynthia M. Simbulan-Rosenthal, Dean S. Rosenthal, Bassem H. Haddad, -- Danith Ly, Jie Zhang, and Mark E. Smulson -- Chapter 4 -- Functional Testing of Human PARP in Proliferation, Endotoxic Shock, and -- Radiosensitivity: A Genetic Rescue Study. -- Zdenko Herceg, Virginie Petrilli, Anton Wutz, Berhard Auer, Marie-Pierre Cros, -- and Zhao-Qi Wang -- Chapter 5 -- PARP Inhibitors as Neuroprotective Agents for Brain Injury -- Joel H. Greenberg, Michelle C. LaPlaca, and Tracy K. Mclntosh -- Chapter 6 -- PARP Inhibitors and Cardioprotection -- Christoph Thiemermann, Nicole Wayman, Michelle C. McDonald, and -- Prabal Kumar Chatterjee -- Chapter 7 -- Neuroprotection of the Retina with 3-Aminobenzamide, a PARP Inhibitor -- Tim T Lam -- Chapter 8 -- Poly(ADP-Ribose) Polymerase Inhibitors and Acute Renal Failure -- Prabal Kumar Chatterjee and Christoph Thiemermann -- Chapter 9 -- Role of Poly(ADP-Ribose) Polymerase Activation in the Pathogenesis of Shock and Inflammation -- Csaba Szabd -- Chapter 10 -- Clinical Development of the Nicotinamides and Benzamides Involving PARP as a Molecular Target. -- Ronald W. Pero, Anders Olsson, Hanna Lindgren, and Tomas Leanderson -- Chapter 11 -- Chemoprotective Effect of a Novel PARP Inhibitor -- Gyorgy Rabloczky, Laszlo Jaszlits, Gyorgy Bardos, Balazs Sumegi, Kalman Tory, -- Ildiko Racz, Beatrix Farkas, Attila Sandor, Zoltan Berente, Erzsebet Osz, -- Judit Szilvassy, Istvan Sziklai, Sandor Bernath, and Peter Literati Nagy -- Chapter 12 -- Beneficial Effect of GPI 6150 Treatment in Multiple Animal Models of Diseases -- Jie Zhang -- Chapter 13 -- Protecting Effect of PARP Inhibition on Ultraviolet Light-Induced Skin Damage -- Beatrix Farkas, Balazs Sumegi, Gyorgy Rabloczky, Bela Csete, Balazs Hodosi, -- Marta Magyarlaki, Sandor Bernath, and Peter Literati Nagy -- Chapter 14 -- Role of Poly(ADP-Ribose) Polymerase Activation in the Pathogenesis of Diabetes Mellitus and Diabetic Vascular Dysfunction. -- Jon G. Mabley, Ldszlo Virdg, and Csaba Szabd -- Chapter 15 -- Therapeutic Targeting of the PARPs: Future Challenges, Future Opportunities -- Myron K. Jacobson and Elaine L. Jacobson.
530 $a Also available in print edition. $b CRC Press (http://www.crcpress.com)
538 $a Mode of access: World Wide Web.
650 0 $a NAD-ADP-ribosyltransferase $x Inhibitors $x Therapeutic use $x Testing. $3 301695
655 7 $a Electronic books. $2 local. $3 214472
700 1 $a Zhang, Jei. $3 301694
776 $z 9780849300738
830 0 $a Pharmacology & toxicology (Boca Raton, Fla.) $3 188791
856 4 0 $u http://marc.crcnetbase.com/ISBN/9781420042405 $q application/PDF $z book distributed by CRC Press. Purchase or institutional license may be required for access.
945 $a URL added - 2010/03/12